Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Recruiting · NCT06412120 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating Safety, Tolerability, and Metabolism of Niraparib | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 4 | 2026-08-05 | NCT06412120 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| University of Miami | 277 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ahmadu Bello University Teaching Hospital (ABUTH) | Zaria | Nigeria | 1 |
| Broward Health | Fort Lauderdale | United States | 4 |
| University of Florida Jacksonville | Jacksonville | United States | 12 |
| University of Miami | Miami | United States | 327 |